Hahn, Matthias

[["dc.bibliographiccitation.firstpage","2512"],["dc.bibliographiccitation.issue","14"],["dc.bibliographiccitation.journal","Angewandte Chemie International Edition"],["dc.bibliographiccitation.lastpage","2514"],["dc.bibliographiccitation.volume","46"],["dc.contributor.author","Nembenna, Sharanappa"],["dc.contributor.author","Roesky, Herbert W."],["dc.contributor.author","Nagendran, Selvarajan"],["dc.contributor.author","Hofmeister, Anja"],["dc.contributor.author","Magull, Joerg"],["dc.contributor.author","Wilbrandt, Peter-J."],["dc.contributor.author","Hahn, Matthias"],["dc.date.accessioned","2018-11-07T11:05:54Z"],["dc.date.available","2018-11-07T11:05:54Z"],["dc.date.issued","2007"],["dc.identifier.doi","10.1002/anie.200604447"],["dc.identifier.isi","000245371300034"],["dc.identifier.pmid","17318933"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/52173"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-v C H Verlag Gmbh"],["dc.relation.issn","1433-7851"],["dc.title","A well-defined hydrocarbon-soluble calcium monofluoride, [{LCaF(thf)}(2)]: The application of soluble calcium derivatives for surface coating"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","39"],["dc.bibliographiccitation.journal","Journal of Neurology"],["dc.bibliographiccitation.lastpage","47"],["dc.bibliographiccitation.volume","255"],["dc.contributor.author","Dodel, Richard"],["dc.contributor.author","Csoti, Ilona"],["dc.contributor.author","Ebersbach, Georg"],["dc.contributor.author","Fuchs, Gerd"],["dc.contributor.author","Hahne, Matthias"],["dc.contributor.author","Kuhn, Wilfried"],["dc.contributor.author","Oechsner, Matthias"],["dc.contributor.author","Jost, Wolfgang H."],["dc.contributor.author","Reichmann, Heinz"],["dc.contributor.author","Schulz, Joerg B."],["dc.date.accessioned","2018-11-07T11:11:37Z"],["dc.date.available","2018-11-07T11:11:37Z"],["dc.date.issued","2008"],["dc.description.abstract","Parkinson's disease (PD) is characterized by its motor impairment. However, non-motor symptoms such as psychiatric disorders, autonomic disturbances and sleep disorders frequently complicate the course of the disease. In particular, psychiatric disturbances including cognitive impairment, depression and psychosis impact these patients considerably. Approximately 31% of PD patients suffer from cognitive impairment and dementia. Currently, two different clinical presentations are distinguished in PD patients, who present with dementia: Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB), which are two different presentations of a single underlying disease process leading to the deposition of cc-synuclein. Clinically, PDD is distinguished from DLB alone by the different temporal manifestations of extrapyramidal motor symptoms. Dementia is characterized by a subtle onset and progressive cognitive decline with a predominant dysexecutive syndrome, which can be accompanied by different behavioral symptoms such as hallucinations, depression, anxiety and sleep disorders. Dysregulation of different neurotransmitters has been associated with cognitive decline, but reduced cholinergic transmission is currently thought to be the pivotal mechanism in the development of cognitive dysfunction. Therefore, cholinesterase inhibitors are used in the treatment of dementia and accompanying behavioral symptoms in PDD and DLB. The occurrence of dementia impacts not only the patients themselves but also their care-givers and family. This article focuses on the clinical issues related to both disorders and is based on a meeting of experts which took place in April 2008 in Dresden."],["dc.description.sponsorship","Glaxo SmithKline"],["dc.identifier.doi","10.1007/s00415-008-5007-0"],["dc.identifier.isi","000259110400007"],["dc.identifier.pmid","18787881"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/53477"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Dr Dietrich Steinkopff Verlag"],["dc.relation.issn","0340-5354"],["dc.title","Lewy body dementia and Parkinson's disease with dementia"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","880"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Astronomische Nachrichten"],["dc.bibliographiccitation.lastpage","893"],["dc.bibliographiccitation.volume","333"],["dc.contributor.author","Puschmann, K. G."],["dc.contributor.author","Denker, C."],["dc.contributor.author","Kneer, F."],["dc.contributor.author","Al Erdogan, N."],["dc.contributor.author","Balthasar, H."],["dc.contributor.author","Bauer, S. M."],["dc.contributor.author","Beck, C."],["dc.contributor.author","Gonzalez, N. Bello"],["dc.contributor.author","Collados, M."],["dc.contributor.author","Hahn, T."],["dc.contributor.author","Hirzberger, J."],["dc.contributor.author","Hofmann, Albrecht W."],["dc.contributor.author","Louis, R. E."],["dc.contributor.author","Nicklas, H."],["dc.contributor.author","Okunev, O."],["dc.contributor.author","Martinez Pillet, V."],["dc.contributor.author","Popow, E."],["dc.contributor.author","Seelemann, T."],["dc.contributor.author","Volkmer, R."],["dc.contributor.author","Wittmann, A. D."],["dc.contributor.author","Woche, M."],["dc.date.accessioned","2018-11-07T09:04:01Z"],["dc.date.available","2018-11-07T09:04:01Z"],["dc.date.issued","2012"],["dc.description.abstract","The GREGOR Fabry-Perot Interferometer (GFPI) is one of three first-light instruments of the German 1.5-meter GREGOR solar telescope at the Observatorio del Teide, Tenerife, Spain. The GFPI uses two tunable etalons in collimated mounting. Thanks to its large-format, high-cadence CCD detectors with sophisticated computer hard- and software it is capable of scanning spectral lines with a cadence that is sufficient to capture the dynamic evolution of the solar atmosphere. The field-of-view (FOV) of 50 ' x38 ' is well suited for quiet Sun and sunspot observations. However, in the vector spectropolarimetric mode the FOV reduces to 25 ' x38 '. The spectral coverage in the spectroscopic mode extends from 530-860 nm with a theoretical spectral resolution of R approximate to 250 000, whereas in the vector spectropolarimetric mode the wavelength range is at present limited to 580-660 nm. The combination of fast narrow-band imaging and post-factum image restoration has the potential for discovery science concerning the dynamic Sun and its magnetic field at spatial scales down to similar to 50 km on the solar surface. (C) 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim"],["dc.identifier.doi","10.1002/asna.201211734"],["dc.identifier.isi","000310799500015"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/25018"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-v C H Verlag Gmbh"],["dc.relation.issn","0004-6337"],["dc.title","The GREGOR Fabry-Perot Interferometer"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","212"],["dc.bibliographiccitation.issue","3-4"],["dc.bibliographiccitation.journal","Archives of Orthopaedic and Trauma Surgery"],["dc.bibliographiccitation.lastpage","216"],["dc.bibliographiccitation.volume","119"],["dc.contributor.author","Lotz, J."],["dc.contributor.author","Gaertner, T."],["dc.contributor.author","Hahn, M."],["dc.contributor.author","Prellwitz, W."],["dc.date.accessioned","2022-06-08T07:59:54Z"],["dc.date.available","2022-06-08T07:59:54Z"],["dc.date.issued","1999"],["dc.identifier.doi","10.1007/s004020050393"],["dc.identifier.pii","LEVMD0AHGWXWH1C0"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/110901"],["dc.notes.intern","DOI-Import GROB-575"],["dc.relation.eissn","1434-3916"],["dc.relation.issn","0936-8051"],["dc.title","Collagen type I metabolism after bone surgery"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2398"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Leukemia"],["dc.bibliographiccitation.lastpage","2406"],["dc.bibliographiccitation.volume","31"],["dc.contributor.author","Hehlmann, R."],["dc.contributor.author","Lauseker, M."],["dc.contributor.author","Saußele, S."],["dc.contributor.author","Pfirrmann, M."],["dc.contributor.author","Krause, S."],["dc.contributor.author","Kolb, H. J."],["dc.contributor.author","Neubauer, A."],["dc.contributor.author","Hossfeld, D. K."],["dc.contributor.author","Nerl, C."],["dc.contributor.author","Gratwohl, A."],["dc.contributor.author","Baerlocher, G. M."],["dc.contributor.author","Heim, D."],["dc.contributor.author","Brümmendorf, T. H."],["dc.contributor.author","Fabarius, A."],["dc.contributor.author","Haferlach, C."],["dc.contributor.author","Schlegelberger, B."],["dc.contributor.author","Müller, M. C."],["dc.contributor.author","Jeromin, S."],["dc.contributor.author","Proetel, U."],["dc.contributor.author","Kohlbrenner, K."],["dc.contributor.author","Voskanyan, A."],["dc.contributor.author","Rinaldetti, S."],["dc.contributor.author","Seifarth, W."],["dc.contributor.author","Spieß, B."],["dc.contributor.author","Balleisen, L."],["dc.contributor.author","Goebeler, M. C."],["dc.contributor.author","Hänel, M."],["dc.contributor.author","Ho, A."],["dc.contributor.author","Dengler, J."],["dc.contributor.author","Falge, C."],["dc.contributor.author","Kanz, L."],["dc.contributor.author","Kremers, S."],["dc.contributor.author","Burchert, A."],["dc.contributor.author","Kneba, M."],["dc.contributor.author","Stegelmann, F."],["dc.contributor.author","Köhne, C.A."],["dc.contributor.author","Lindemann, H. W."],["dc.contributor.author","Waller, C. F."],["dc.contributor.author","Pfreundschuh, M."],["dc.contributor.author","Spiekermann, K."],["dc.contributor.author","Berdel, W. E."],["dc.contributor.author","Müller, L."],["dc.contributor.author","Edinger, M."],["dc.contributor.author","Mayer, J."],["dc.contributor.author","Beelen, D. W."],["dc.contributor.author","Bentz, M."],["dc.contributor.author","Link, H."],["dc.contributor.author","Hertenstein, B."],["dc.contributor.author","Fuchs, R."],["dc.contributor.author","Wernli, M."],["dc.contributor.author","Schlegel, F."],["dc.contributor.author","Schlag, R."],["dc.contributor.author","de Wit, M."],["dc.contributor.author","Trümper, L."],["dc.contributor.author","Hebart, H."],["dc.contributor.author","Hahn, M."],["dc.contributor.author","Thomalla, J."],["dc.contributor.author","Scheid, C."],["dc.contributor.author","Schafhausen, P."],["dc.contributor.author","Verbeek, W."],["dc.contributor.author","Eckart, M. J."],["dc.contributor.author","Gassmann, W."],["dc.contributor.author","Pezzutto, A."],["dc.contributor.author","Schenk, M."],["dc.contributor.author","Brossart, P."],["dc.contributor.author","Geer, T."],["dc.contributor.author","Bildat, S."],["dc.contributor.author","Schäfer, E."],["dc.contributor.author","Hochhaus, A."],["dc.contributor.author","Hasford, J."],["dc.date.accessioned","2019-11-25T13:09:15Z"],["dc.date.accessioned","2021-10-27T13:21:33Z"],["dc.date.available","2019-11-25T13:09:15Z"],["dc.date.available","2021-10-27T13:21:33Z"],["dc.date.issued","2017"],["dc.description.abstract","Chronic myeloid leukemia (CML)-study IV was designed to explore whether treatment with imatinib (IM) at 400 mg/day (n=400) could be optimized by doubling the dose (n=420), adding interferon (IFN) (n=430) or cytarabine (n=158) or using IM after IFN-failure (n=128). From July 2002 to March 2012, 1551 newly diagnosed patients in chronic phase were randomized into a 5-arm study. The study was powered to detect a survival difference of 5% at 5 years. After a median observation time of 9.5 years, 10-year overall survival was 82%, 10-year progression-free survival was 80% and 10-year relative survival was 92%. Survival between IM400 mg and any experimental arm was not different. In a multivariate analysis, risk group, major-route chromosomal aberrations, comorbidities, smoking and treatment center (academic vs other) influenced survival significantly, but not any form of treatment optimization. Patients reaching the molecular response milestones at 3, 6 and 12 months had a significant survival advantage. For responders, monotherapy with IM400 mg provides a close to normal life expectancy independent of the time to response. Survival is more determined by patients' and disease factors than by initial treatment selection. Although improvements are also needed for refractory disease, more life-time can currently be gained by carefully addressing non-CML determinants of survival."],["dc.identifier.doi","10.1038/leu.2017.253"],["dc.identifier.isbn","28804124"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16719"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/92031"],["dc.language.iso","en"],["dc.notes.intern","Migrated from goescholar"],["dc.relation.eissn","1476-5551"],["dc.relation.issn","1476-5551"],["dc.relation.issn","0887-6924"],["dc.relation.orgunit","Universitätsmedizin Göttingen"],["dc.rights","CC BY-NC-ND 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by-nc-nd/4.0"],["dc.subject.ddc","610"],["dc.title","Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","723"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Advanced Engineering Materials"],["dc.bibliographiccitation.lastpage","731"],["dc.bibliographiccitation.volume","17"],["dc.contributor.author","Borchers, Christine"],["dc.contributor.author","Stoltenhoff, Thorsten"],["dc.contributor.author","Hahn, Matthias"],["dc.contributor.author","Schulze, Matthias"],["dc.contributor.author","Assadi, Hamid"],["dc.contributor.author","Suryanarayana, Challapalli"],["dc.contributor.author","Gaertner, Frank"],["dc.contributor.author","Klassen, Thomas"],["dc.date.accessioned","2018-11-07T09:57:45Z"],["dc.date.available","2018-11-07T09:57:45Z"],["dc.date.issued","2015"],["dc.description.abstract","There is an increasing interest in cold spraying, which is commonly characterized as a solid-state deposition process offering minimal structural changes. The present paper refutes this common perception by examining the structural changes in MCrAlY as induced by cold spraying (CS). The cold-sprayed coatings were characterized for phase composition and microstructural features using X-ray diffraction, scanning electron microscopy (SEM), and transmission electron microscopy (TEM) techniques. These results are compared with those obtained from the feedstock powder, as well as those obtained from ball-milled powder. An extensive phase transition from bcc to fcc is observed after both CS and after ball milling. In CS, in addition, there is evidence for substantial grain refinement, which is not observed after ball milling."],["dc.identifier.doi","10.1002/adem.201400174"],["dc.identifier.isi","000354417300019"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37231"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","1527-2648"],["dc.relation.issn","1438-1656"],["dc.relation.orgunit","Institut für Materialphysik"],["dc.title","Strain-Induced Phase Transformation of MCrAlY"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","638"],["dc.bibliographiccitation.journal","Applied Surface Science"],["dc.bibliographiccitation.lastpage","644"],["dc.bibliographiccitation.volume","307"],["dc.contributor.author","Eberl, Christian"],["dc.contributor.author","Döring, Florian"],["dc.contributor.author","Liese, Tobias"],["dc.contributor.author","Schlenkrich, Felix"],["dc.contributor.author","Roos, Burkhard"],["dc.contributor.author","Hahn, Matthias"],["dc.contributor.author","Hoinkes, Thomas"],["dc.contributor.author","Rauschenbeutel, Arno"],["dc.contributor.author","Osterhoff, Markus"],["dc.contributor.author","Salditt, Tim"],["dc.contributor.author","Krebs, Hans-Ulrich"],["dc.date.accessioned","2017-09-07T11:45:42Z"],["dc.date.available","2017-09-07T11:45:42Z"],["dc.date.issued","2014"],["dc.description.abstract","Recently, we demonstrated unprecedented sub-5 nm point focusing of hard X-rays (at 7.9 key) based on the combination of a high gain Kirkpatrick-Baez (KB) mirror system and a high resolution W/Si multilayer zone plate (MZP). This MZP was prepared by the combination of pulsed laser deposition (PLD) and focused ion beam (FIB). Despite the small focus size, the MZP's quality suffered from sufficient but comparatively low efficiency (2%). In this paper we discuss how to overcome limitations of MZP fabrication by PLD by investigating the material systems W/Si, WIZr02, and Ta205/Zr02. We give a detailed description on the optimization processes for the deposition of smooth multilayers with highly precise layer thicknesses on a rotating wire. Furthermore, we present our latest results regarding a Ta205/Zr02 MZP, which has been proven already to be a system of high potential in the very first experiments as the efficiency reached 6.9% (at 18 keV). 2014 Elsevier B.V. All rights reserved."],["dc.identifier.doi","10.1016/j.apsusc.2014.04.089"],["dc.identifier.gro","3142089"],["dc.identifier.isi","000336596700088"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/4422"],["dc.language.iso","en"],["dc.notes.intern","WoS Import 2017-03-10 / Funder: Deutsche Forschungsgemeinschaft [SFB 755, SFB 1073]"],["dc.notes.status","final"],["dc.notes.submitter","PUB_WoS_Import"],["dc.relation","SFB 755: Nanoscale Photonic Imaging"],["dc.relation","SFB 1073: Kontrolle von Energiewandlung auf atomaren Skalen"],["dc.relation","SFB 1073 | Topical Area A | A02 Verständnis und Manipulation von Dissipationskanälen des Energietransports"],["dc.relation.eissn","1873-5584"],["dc.relation.issn","0169-4332"],["dc.relation.orgunit","Institut für Materialphysik"],["dc.relation.orgunit","Institut für Röntgenphysik"],["dc.relation.workinggroup","RG Salditt (Structure of Biomolecular Assemblies and X-Ray Physics)"],["dc.subject.gro","x-ray optics"],["dc.title","Fabrication of laser deposited high-quality multilayer zone plates for hard X-ray nanofocusing"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","133"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Neurobiology of Disease"],["dc.bibliographiccitation.lastpage","138"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Gerber, Joachim"],["dc.contributor.author","Bottcher, T."],["dc.contributor.author","Hahn, M."],["dc.contributor.author","Siemer, A."],["dc.contributor.author","Bunkowski, Stephanie"],["dc.contributor.author","Nau, R."],["dc.date.accessioned","2018-11-07T10:48:42Z"],["dc.date.available","2018-11-07T10:48:42Z"],["dc.date.issued","2004"],["dc.description.abstract","Tumor necrosis factor-alpha (TNF-alpha) is critically involved in inflammation and may participate in hippocampal injury in bacterial meningitis. In a mouse model of ceftriaxone-treated pneumococcal meningitis, spatial memory and motor performance of TNF-alpha-deficient (n = 57) and control mice (n = 55) were investigated. After infection, therapy was initiated with ceftriaxone (100 mg/kg twice daily for 5 days). Sixty-three percent TNF-alpha-deficient mice and 40% control animals died within 6 days (Fisher's exact test: P = 0.02). TNF-alpha-deficient mice surviving pneumococcal meningitis took substantially longer to reach the hidden platform than controls, and the distance of swim tracks was longer (P = 0.02). The swim speed in both groups was similar (P = 0.59). The proliferation of dentate granule cells was lower in TNF-alpha-deficient than in wild-type mice (P = 0.03). In pneumococcal meningitis, TNF-alpha deficiency caused increased mortality and stronger deficits in spatial memory possibly due to impaired neurogenesis. (C) 2004 Elsevier Inc. All rights reserved."],["dc.identifier.doi","10.1016/j.nbd.2004.01.013"],["dc.identifier.isi","000221365300015"],["dc.identifier.pmid","15207270"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/48257"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Academic Press Inc Elsevier Science"],["dc.relation.issn","0969-9961"],["dc.title","Increased mortality and spatial memory deficits in TNF-alpha-deficient mice in ceftriaxone-treated experimental pneumococcal meningitis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","8"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Computer Physics Communications"],["dc.bibliographiccitation.lastpage","25"],["dc.bibliographiccitation.volume","180"],["dc.contributor.author","Allanach, B. C."],["dc.contributor.author","Balazs, C."],["dc.contributor.author","Belanger, G."],["dc.contributor.author","Bernhardt, M."],["dc.contributor.author","Boudjema, F."],["dc.contributor.author","Choudhury, D."],["dc.contributor.author","Desch, Klaus"],["dc.contributor.author","Ellwanger, U."],["dc.contributor.author","Gambino, P."],["dc.contributor.author","Godbole, R."],["dc.contributor.author","Goto, T."],["dc.contributor.author","Guasch, J."],["dc.contributor.author","Guchait, M."],["dc.contributor.author","Hahn, T."],["dc.contributor.author","Heinemeyer, S."],["dc.contributor.author","Hugonie, C."],["dc.contributor.author","Hurth, T."],["dc.contributor.author","Kraml, S."],["dc.contributor.author","Kreiss, S."],["dc.contributor.author","Lykken, J."],["dc.contributor.author","Moortgat, F."],["dc.contributor.author","Moretti, S."],["dc.contributor.author","Penaranda, S."],["dc.contributor.author","Plehn, Tilman"],["dc.contributor.author","Porod, Werner"],["dc.contributor.author","Pukhov, A."],["dc.contributor.author","Richardson, P."],["dc.contributor.author","Schumacher, M."],["dc.contributor.author","Silvestrini, L."],["dc.contributor.author","Skands, P."],["dc.contributor.author","Slavich, P."],["dc.contributor.author","Spin, Joshua M."],["dc.contributor.author","Weiglein, G."],["dc.contributor.author","Wienemann, Peter"],["dc.date.accessioned","2018-11-07T08:34:11Z"],["dc.date.available","2018-11-07T08:34:11Z"],["dc.date.issued","2009"],["dc.description.abstract","The Supersymmetry Les Houches Accord (SLHA) provides a universal set of conventions for conveying spectral and decay information for supersymmetry, analysis problems in high energy physics. Here, we propose extensions of the conventions of the first SLHA to include various generalisations: the minimal supersymmetric standard model with violation of CP, R-parity, and flavour, as well as the simplest next-to-minimal model. (C) 2008 Elsevier B.V. All rights reserved."],["dc.identifier.doi","10.1016/j.cpc.2008.08.004"],["dc.identifier.isi","000262065100002"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/17763"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Bv"],["dc.relation.issn","0010-4655"],["dc.title","SUSY Les Houches Accord 2"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","198"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Cellular Oncology"],["dc.bibliographiccitation.lastpage","199"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Barbus, Sebastian"],["dc.contributor.author","Tews, B."],["dc.contributor.author","Hahn, M."],["dc.contributor.author","Radlwimmer, Bernhard"],["dc.contributor.author","Hartmann, C."],["dc.contributor.author","Felsberg, Joerg"],["dc.contributor.author","Krex, Dietmar"],["dc.contributor.author","Schackert, Gabriele"],["dc.contributor.author","Martinez, R."],["dc.contributor.author","Reifenberger, Guido"],["dc.contributor.author","Lichter, Peter"],["dc.date.accessioned","2018-11-07T08:47:16Z"],["dc.date.available","2018-11-07T08:47:16Z"],["dc.date.issued","2010"],["dc.identifier.isi","000276461900083"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/20909"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Ios Press"],["dc.publisher.place","Amsterdam"],["dc.relation.conference","Congress of the International-Society-for-Cellular-Oncology"],["dc.relation.eventlocation","Dresden, GERMANY"],["dc.relation.issn","1570-5870"],["dc.title","RETINOIC ACID SIGNALING ACTIVATES DIFFERENT TARGETS IN THE TUMORS OF LONG-TERM COMPARED TO SHORT-TERM SURVIVORS OF GLIOBLASTOMA"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]